Presentation of the year-end report 2022
Oncopeptides AB (publ) published the report for the fourth quarter and the 2022 year-end report, on February 16, 2023. Investors, financial analysts, and media were invited to participate in a webcast and a following QnA session on the same day. The event was hosted by Monica Shaw, CEO, together with Holger Lembrér, CFO, and Jakob Lindberg, CSO. The presentation was held in English.
The webcast was recorded and can be found on the link below.
https://ir.financialhearings.com/oncopeptides-q4-2022
You can also look at the webcast presentation in pdf, se the document below.